BioNTech SE American Depositary Share BNTX
$113.12
+21.96%
at last close
Market Cap$23.30 billion
P/E Ratio—
Div Yield—
Volume8.78M
52-Week Range
$79.52$124.00
Analyst Ratings
- Consensus
- Buy — 10 Buy · 3 Hold · 0 Sell (13 analysts)
- Avg. Price Target
- $127.31 (+12.5% upside)
Key Stats
- Today's Range
- $107.18 – $116.00
- 50-Day Range
- $84.95 – $116.00
- 52-Week Range
- $79.52 – $124.00
- Volume
- 8.78 million shs
- Average Volume
- 1.14 million shs
- Market Cap
- $23.30 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.33%
- Days to Cover
- 1.66
About BioNTech SE American Depositary Share
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Related Stocks
Compare head-to-head: BNTX vs NVDA·BNTX vs AAPL·BNTX vs GOOGL·BNTX vs GOOG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.